ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
This study, called ACCESS, is looking at better ways to provide cervical cancer screening and treatment to women living with HIV in Nigeria. It compares two approaches: "Core Implementation Strategies" and "Core+ Enhanced Implementation Strategies." The Core strategies involve ongoing consultation, educational meetings, strengthening referral systems, and preparing patients to be active participants. The Core+ strategies include all of the Core strategies plus community engagement and using "Smart Cards" to help patients stay involved. The study aims to see how well these approaches help women get screened, treated, and stay in care. You may be able to join if you are a woman living with HIV, between 25 and 64 years old. The study is currently unclear about its recruitment status.
- Study design
- This study plans to include 2436 women and compares two different sets of strategies for providing cervical cancer care.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will measure how many people are reached at 12 months after joining and how well the services continue to be used (sustainment) 3 months before the study ends.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
At a glance
Conditions
Where it's being run
2 sites across 2 statesStudy leadership
- Gregory Aarons, PhD · PRINCIPAL_INVESTIGATOR · University of California, San Diego
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Reach12 months after enrollment
Percent of WLHIV who had cervical cancer (CC) screening
- Sustainment3 months prior to study completion
Provider Report of Sustainment Scale (PRESS; Moullin et al., 2021). The PRESS has 3-items scored from 0 "not at all" to 4 "to a very great extent" where higher scores indicate better evidence-based practice sustainment.